Skip to main content

Table 1 Number of patients per type of cancer that have NTX measurements on month t (NTXt)

From: Modelling cancer outcomes of bone metastatic patients: combining survival data with N-Telopeptide of type I collagen (NTX) dynamics through joint models

Cancer type

Baseline

NTX1

NTX3

NTX6

NTX9

NTX12

Breast

90

67

58

48

32

26

Prostate

26

20

17

15

11

5

Others

31

18

15

9

5

3

Totals

147

87

90

72

48

34

  1. Others include the following types of cancer: lung, kidney, gastric, sarcoma, hepatobiliary, bladder, endometrium, cervix, neuroendocrine, osteoblastoma and unknown primary tumor